These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1757 related articles for article (PubMed ID: 8226281)

  • 21. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
    Sheu JR; Chao SH; Yen MH; Huang TF
    Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist.
    Wang WJ; Huang TF
    Thromb Haemost; 2001 Oct; 86(4):1077-86. PubMed ID: 11686327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    Humphries MJ; Yamada KM; Olden K
    J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines.
    Heinmöller E; Schropp T; Kisker O; Simon B; Seitz R; Weinel RJ
    Scand J Gastroenterol; 1995 Oct; 30(10):1008-16. PubMed ID: 8545606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia.
    Sheu JR; Hung WC; Wu CH; Ma MC; Kan YC; Lin CH; Lin MS; Luk HN; Yen MH
    Circulation; 1999 Jun; 99(23):3056-62. PubMed ID: 10368125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the binding character of triflavin on resting and activated alpha(IIb)beta(3) integrin in human platelets by electron microscopy.
    Chuang WJ; Wu CH; Huang HN; Chen SH; Hsiao G; Lin CH; Sheu JR
    Thromb Res; 2003 Jan; 109(1):37-46. PubMed ID: 12679130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triflavin, an RGD-containing antiplatelet peptide, binds to GpIIIa of ADP-stimulated platelets.
    Sheu JR; Teng CM; Huang TF
    Biochem Biophys Res Commun; 1992 Dec; 189(2):1236-42. PubMed ID: 1472031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity.
    Knapp A; Degenhardt T; Dodt J
    J Biol Chem; 1992 Dec; 267(34):24230-4. PubMed ID: 1447173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs.
    Lian L; Li W; Li ZY; Mao YX; Zhang YT; Zhao YM; Chen K; Duan WM; Tao M
    Oncol Lett; 2013 Feb; 5(2):675-680. PubMed ID: 23420392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom.
    Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF
    Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.
    Alonso-Escolano D; Strongin AY; Chung AW; Deryugina EI; Radomski MW
    Br J Pharmacol; 2004 Jan; 141(2):241-52. PubMed ID: 14691052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma-dependent and -independent mechanisms of platelet aggregation induced by human tumour cell lines.
    Scarlett JD; Thurlow PJ; Connellan JM; Louis CJ
    Thromb Res; 1987 Jun; 46(5):715-26. PubMed ID: 3629545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
    Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
    Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].
    Pastorova VE; Liapina LA; Cherkasova KA; Ashmarin IP
    Usp Fiziol Nauk; 1999; 30(2):80-91. PubMed ID: 10420478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF
    J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.